In vitro activities of PNU-100480 and linezolid against drug-susceptible and drug-resistant Mycobacterium tuberculosis isolates.

作者信息

Yip Peter C W, Kam K M, Lam Edman T K, Chan Raphael C Y, Yew W W

出版信息

Int J Antimicrob Agents. 2013 Jul;42(1):96-7. doi: 10.1016/j.ijantimicag.2013.03.002. Epub 2013 May 15.

DOI:10.1016/j.ijantimicag.2013.03.002

PMID:23684005

Abstract

摘要

相似文献

In vitro activities of PNU-100480 and linezolid against drug-susceptible and drug-resistant Mycobacterium tuberculosis isolates.

Int J Antimicrob Agents. 2013 Jul;42(1):96-7. doi: 10.1016/j.ijantimicag.2013.03.002. Epub 2013 May 15.

In vitro susceptibility of Mycobacterium tuberculosis clinical isolates to garenoxacin and DA-7867.

Antimicrob Agents Chemother. 2005 Oct;49(10):4351-3. doi: 10.1128/AAC.49.10.4351-4353.2005.

In vitro activity of linezolid against Mycobacterium tuberculosis strains isoalted from Western Turkey.

Jpn J Infect Dis. 2009 Sep;62(5):384-5.

In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculous drugs.

Antimicrob Agents Chemother. 2003 Jan;47(1):416-7. doi: 10.1128/AAC.47.1.416-417.2003.

In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis complex isolated in Taiwan over 10 years.

Antimicrob Agents Chemother. 2008 Jun;52(6):2226-7. doi: 10.1128/AAC.00414-07. Epub 2008 Apr 7.

[Evaluation of the mycobacterium efficacy of linezolid in vitro].

Zhonghua Jie He He Hu Xi Za Zhi. 2011 Aug;34(8):575-8.

First linezolid-resistant clinical isolates of Mycobacterium tuberculosis.

Antimicrob Agents Chemother. 2007 Apr;51(4):1534-6. doi: 10.1128/AAC.01113-06. Epub 2007 Jan 22.

Post-antibiotic effects of linezolid and other agents against Mycobacterium tuberculosis.

Int J Antimicrob Agents. 2008 Apr;31(4):395-6. doi: 10.1016/j.ijantimicag.2007.12.002. Epub 2008 Feb 12.

[Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates].

Mikrobiyol Bul. 2009 Apr;43(2):293-7.

In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis from Shenyang, north of China.

Indian J Med Microbiol. 2015 Feb;33 Suppl:164-5. doi: 10.4103/0255-0857.150967.

引用本文的文献

Tackling Nontuberculous Mycobacteria by Repurposable Drugs and Potential Leads from Natural Products.

Curr Top Med Chem. 2024;24(15):1291-1326. doi: 10.2174/0115680266276938240108060247.

Differential distribution of linezolid in diseased and nondiseased bones in patients with spinal tuberculosis.

BMC Infect Dis. 2024 Jan 5;24(1):50. doi: 10.1186/s12879-023-08970-x.

Targeting iron-scavenging tools: a recent update on siderophores inhibitors.

RSC Med Chem. 2023 Sep 6;14(10):1885-1913. doi: 10.1039/d3md00201b. eCollection 2023 Oct 18.

Novel oxazolidinones harbor potent activity against the clinical isolates of multidrug-resistant in China.

Front Med (Lausanne). 2022 Nov 29;9:1067516. doi: 10.3389/fmed.2022.1067516. eCollection 2022.

and Activity of Oxazolidinone Candidate OTB-658 against Mycobacterium tuberculosis.

Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0097421. doi: 10.1128/AAC.00974-21. Epub 2021 Aug 16.

Efflux-Mediated Resistance to New Oxazolidinones and Pleuromutilin Derivatives in Escherichia coli with Class Specificities in the Resistance-Nodulation-Cell Division-Type Drug Transport Pathways.

Antimicrob Agents Chemother. 2019 Aug 23;63(9). doi: 10.1128/AAC.01041-19. Print 2019 Sep.

Susceptibilities of MDR Mycobacterium tuberculosis isolates to unconventional drugs compared with their reported pharmacokinetic/pharmacodynamic parameters.

J Antimicrob Chemother. 2017 Jun 1;72(6):1678-1687. doi: 10.1093/jac/dkx022.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验